Boston, MACIK 13169264 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
89 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Popular Inc | 682.3K | $84.96M | 7.0% | −204.2K | Reduced |
| 2 | Jazz Pharmaceuticals PLC | 432.5K | $73.52M | 6.1% | −81.0K | Reduced |
| 3 | Linde PLC | 133.9K | $57.09M | 4.7% | −34.5K | Reduced |
| 4 | Smurfit Westrock PLC |
| 1.45M |
| $55.98M |
| 4.6% |
| −295.0K |
| Reduced |
| 5 | United Therapeutics Corp Del | 103.7K | $50.50M | 4.2% | −18.4K | Reduced |
| 6 | Mks Inc. | 265.1K | $42.36M | 3.5% | −136.2K | Reduced |
| 7 | Cvs Health Corp | 525.3K | $41.69M | 3.5% | −77.3K | Reduced |
| 8 | Jpmorgan Chase & Co. | 117.3K | $37.78M | 3.1% | −19.2K | Reduced |
| 9 | Lantheus Hldgs Inc | 538.0K | $35.80M | 3.0% | −99.3K | Reduced |
| 10 | Slm Corp | 1.25M | $33.71M | 2.8% | −165.7K | Reduced |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio